Nutex Health (NUTX) | Stock Overview & Key Data
Nutex Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $5,250.00 on April 4, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nutex Health
NUTX
|
772.96M Small-cap | 11.20% | -9.74% | 18.70% | 0.82% | -10.37% | -23.03% | 90.34% | -90.45% | -90.45% | -90.45% | -90.45% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | -7.37% | -14.97% | -32.96% | -25.38% | -22.78% | -0.75% | 38.02% | 77.08% | 384.44% | 1,008.79% | 1,116.39% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | -8.96% | -11.07% | -32.13% | -22.00% | -17.35% | 3.88% | 135.08% | 158.85% | 506.43% | 601.28% | 444.47% |
|
Surgery Partners
SGRY
|
1.86B Small-cap | 0.22% | -4.86% | -2.95% | -20.72% | -11.47% | -43.41% | -66.42% | -77.94% | -5.72% | -27.51% | -27.51% |
| 1.91B Small-cap | 0.88% | -2.54% | 10.64% | -6.23% | 2.58% | 52.23% | 53.97% | -32.60% | -68.09% | -39.53% | -4.27% | |
|
Astrana Health
ASTH
|
1.88B Small-cap | -4.80% | 4.83% | 49.61% | 59.30% | 45.40% | 51.75% | 11.50% | 1.87% | 585.25% | 637.65% | 637.65% |
Ownership & Short Interest
Calculate Your Nutex Health Investment Returns
Long-Term Investment Performance Analysis
Nutex Health stock price in Apr 2022 was $1,351.50, A $1,000.00 lump sum investment in Nutex Health made 4 years ago would be worth approximately $98.28 today, representing a negative return of -90.17%. This translates to an annualized return (CAGR) of -42.71%.
4 Years 1 Month Investment Scenario (Apr 2022 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NUTX's 52-week high and low?
- In the last 52 weeks, Nutex Health reached a high of $193.07 (on December 30, 2025) and a low of $77.21 (on September 2, 2025).
- What is the market cap and P/E ratio for NUTX?
- Curious about Nutex Health's size and valuation? Its market capitalization stands at 772.96M. When it comes to valuation, the P/E ratio (trailing twelve months) is 10.34, and the forward P/E (looking ahead) is 5.33.
- Does NUTX pay dividends? If so, what's the yield?
- As for dividends, Nutex Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nutex Health's main competitors or similar companies to consider before investing?
When looking at Nutex Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities -0.75% 38.02% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 3.88% 135.08% Surgery Partners
SGRY1.86B Healthcare Medical Care Facilities -43.41% -66.42% Pediatrix Medical
MD1.91B Healthcare Medical Care Facilities 52.23% 53.97% Astrana Health
ASTH1.88B Healthcare Medical Care Facilities 51.75% 11.50% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nutex Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Nutex Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 58.94%, the Debt to Equity ratio from the most recent quarter is 82.99, and its Gross Profit Margin stands at 30.42%.
- What is the recent revenue and earnings growth for NUTX?
- Looking at Nutex Health's growth, its revenue over the trailing twelve months (TTM) was $875M. Compared to the same quarter last year (YoY), quarterly revenue grew by -41.10%, and quarterly earnings saw a YoY growth of -80.80%.
- How much of NUTX stock is held by insiders and institutions?
- Wondering who owns Nutex Health stock? Company insiders (like executives and directors) hold about 28.66% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 40.16%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.